The clinical cure rate was significantly lower in the amoxicillin-clavulanate group than in the ciprofloxacin group (58% vs. 77%), regardless of whether the pathogens were susceptible or resistant ...

Enhertu, a cancer drug by AstraZeneca, was the top-selling new drug in 2024 with sales of nearly Rs 58 crore. Over 3,100 new brands were launched, generating sales of Rs 1,097 crore. The cardiac, anti ...